These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [CLINICAL IMPROVEMENTS OBTAINED IN ADVANCED CANCER PATIENTS WITH TREATMENT WITH THALIDOMIDE ASSOCIATED WITH HORMONES]. MAUAD MJ An Paul Med Cir; 1963 Jul; 86():13-40. PubMed ID: 14081473 [No Abstract] [Full Text] [Related]
5. [ON THE HORMONE-DEPENDENCE OF SOME THYROID CANCERS]. MONSAINGEON A; CAMUS JL Mem Acad Chir (Paris); 1964 Nov 4-18; 90():816-26. PubMed ID: 14231267 [No Abstract] [Full Text] [Related]
6. CANCER OF THE THYROID IN CHILDHOOD AND ADOLESCENCE. BONGIOVANNI AM; DIGEORGE AM Am J Med Sci; 1963 Dec; 246():734-49. PubMed ID: 14085233 [No Abstract] [Full Text] [Related]
7. THE CURRENT STATUS OF CHEMOTHERAPY AND HORMONE THERAPY FOR CANCER. WRIGHT JC; MEDREK TJ; WALKER DG; LYONS MM Prog Clin Cancer; 1965; 10():264-307. PubMed ID: 14283910 [No Abstract] [Full Text] [Related]
8. PALLIATIVE MANAGEMENT OF CANCER. COTTER WM N Z Med J; 1965 Jun; 64():318-20. PubMed ID: 14328114 [No Abstract] [Full Text] [Related]
9. [Morphology and clinical picture of thyroid cancer]. Meng W; Lorenz G Z Arztl Fortbild (Jena); 1983; 77(15):635-8. PubMed ID: 6356642 [No Abstract] [Full Text] [Related]
10. [Use of new molecules in the treatment of advanced thyroid cancer]. Galofré JC; Gómez-Sáez JM; Álvarez Escola C; Álvarez García E; Anda Apiñaniz E; Calleja A; Donnay S; Lucas-Martin A; Menéndez Torre E; Navarro González E; Pereg V; Pérez Corral B; Santamaría Sandi J; Riesco Eizaguirre G; Zafón Llopis C; Endocrinol Nutr; 2011 Oct; 58(8):381-6. PubMed ID: 21924966 [No Abstract] [Full Text] [Related]
11. [ON EXPERIENCE WITH INTERNAL (COMBINED CYTOSTATIC-RESISTANCE INCREASING) CANCER THERAPY]. SIEBERTH E Krebsarzt; 1964; 19():104-13. PubMed ID: 14128388 [No Abstract] [Full Text] [Related]
12. [THE SIGNIFICANCE OF NUCLEAR MORPHOLOGICAL SEX DETERMINATION IN HORMONAL THERAPY OF BREAST CANCER]. GLAESER A; REDING R Bruns Beitr Klin Chir; 1964 Nov; 209():326-9. PubMed ID: 14333096 [No Abstract] [Full Text] [Related]
13. [THE VARIOUS MEANS OF ANTICANCER THERAPY. TODAY'S REALITIES; HOPES FOR TOMORROW]. MATHE G Tech Hosp Med Soc Sanit; 1964 Jan; 19():72-5. PubMed ID: 14110199 [No Abstract] [Full Text] [Related]
14. [ON THE PRESENT STATUS OF MAMMARY CANCER THERAPY]. GITSCHMANN W Dtsch Med J; 1965 Jan; 16():1-9 CONTD. PubMed ID: 14262590 [No Abstract] [Full Text] [Related]
15. [Hormonal therapy in oncologic treatment: pathogenic hypotheses and interactions between thyroid and breast pathologies]. Parmeggiani D; Malinconico FA; Moccia G; Idà DN; Ripa C; Scala R; Foroni F; Gilio F; Cognetti C; Iside G; Agresti M Tumori; 2003; 89(4 Suppl):215-9. PubMed ID: 12903598 [TBL] [Abstract][Full Text] [Related]
16. [DISCUSSIONS ON MAMMARY CANCER. 3. NON-HORMONAL PALLIATIVE TREATMENT]. LOKKERBOL H; VAN SLOOTENE ; DEN HERDERBA ; EPHRAIM KH; VAN VAERENBERGHP ; FRENKEL M; DE LANGE SA; OKKER JJ; BAARTDELAFAILLE RL Jaarb Kankeronderz Kankerbestrijd Ned; 1963; 13():39-50. PubMed ID: 14182749 [No Abstract] [Full Text] [Related]
18. [Thyrotropic and thyroid function after antineoplastic treatment in infants]. Mussa GC; Bona G; Cordero di Montezemolo L; Silvestro L; Italiano F; Ardissone P Minerva Pediatr; 1982 Feb; 34(4):151-9. PubMed ID: 7087925 [No Abstract] [Full Text] [Related]
19. Anticancer drugs and hormones as adjuvants to the radiation therapy of cancer. ANDREWS JR; SHAFER IE N C Med J; 1953 Sep; 14(9):413-20. PubMed ID: 13099637 [No Abstract] [Full Text] [Related]
20. HORMONAL CONTROL OF CANCER. STRONG JA Proc R Soc Med; 1963 Aug; 56(8):665-70. PubMed ID: 14052451 [No Abstract] [Full Text] [Related] [Next] [New Search]